The Optejet® ophthalmic drug device is designed to precisely administer medication to the eye, potentially treating patients' conditions through gentler, more efficient dosing.
Read Press ReleaseWhile traditional eye drop bottles require hand-eye coordination and deliver four to five times more medication than the human eye can hold, the Optejet® dispenser's human-centric design administers an easier, more accurate and appropriate dose directly where it is needed in the eye.
Read Press Release3D Human Tissue Retina Vasculature model provides a new and novel approach to rapidly and efficiently screening numerous therapies for diabetic retinopathy and diabetic macular edema.
Read Press ReleaseAppointment reflects Glauconix Biosciences' expansion of their 3D Human Tissue model platform within the Ophthalmology space and brings their second commercial model closer to market
Read Press ReleaseDiaton Tonometer is a unique and innovative tonometry instrument, unlike all others; allows to accurately measure Intraocular Pressure (IOP) through the eyelid and sclera without touching the eyeball. With Diaton use, there is no risk of infection or need for sterilization, as there is no contact with the mucous membrane. Zero-contact with the cornea or influence of corneal biomechanics on Diaton IOP results provides more accurate glaucoma diagnosis.
Read Press ReleaseThe global Ophthalmology devices market is expected to reach $42.0 billion by 2021. This report analyzes the ophthalmology devices market in terms of market revenue ($ million) for all segments.
Read Press ReleaseKey-Whitman Eye Center is keeping up with the latest technology in the diagnosis and treatment of dry eyes and was recently certified by TearLab as an "Accredited Dry Eye Center".
Read Press ReleaseBarbara Wirostko, Senior Medical Director, Team Lead Ophthalmology, Pfizer will give a presentation at GTCbio's 2nd Annual Ocular Disease Drug & Discovery Conference, May 27 - 28, 2010 in Boston, MA.
Read Press Release